Tekmira receives $14.5M milestone payment from Monsanto Tekmira Pharmaceuticals (TKMR) confirmed that it has received $14.5M of the net $16.5M in near term payments as outlined in the terms of an option agreement signed with Monsanto (MON), which supports the application of Tekmira's proprietary delivery technology and related intellectual property for use in agriculture. The agreement follows Monsanto's initial testing of Tekmira's proprietary delivery technology and the demonstration of initial positive results from use of that technology in the field of agriculture. The companies' agreement and research collaboration is focused on the development of new innovative biological solutions for farmers, which have the potential to provide new options for sustainable pest, virus and weed control.
News For TKMR;MON From The Last 14 Days
Check below for free stories on TKMR;MON the last two weeks.